Overview
Kim De Veirman practices in Brussels, Belgium. De Veirman is rated as a Distinguished expert by MediFind in the treatment of Multiple Myeloma. Their top areas of expertise are Multiple Myeloma, Cerebral Hypoxia, Osteolysis Syndrome Recessive, and Mantle Cell Lymphoma (MCL).
Their clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 55 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDe Veirman isDistinguished. Learn about Multiple Myeloma.
- Experienced
- Acute Myeloid Leukemia (AML)De Veirman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDe Veirman isExperienced. Learn about B-Cell Lymphoma.
- Cerebral HypoxiaDe Veirman isExperienced. Learn about Cerebral Hypoxia.
- LeukemiaDe Veirman isExperienced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)De Veirman isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDe Veirman isExperienced. Learn about Non-Hodgkin Lymphoma.